Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Clinical trial NCT04195828 · COMPLETED
Trial details
- NCT number
- NCT04195828
- Sponsor
- Fujian Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2022-07-22
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.